GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fosun Pharmaceutical (Group) Co Ltd (STU:08HH) » Definitions » Purchase Of Property, Plant, Equipment

Shanghai Fosun Pharmaceutical (Group) Co (STU:08HH) Purchase Of Property, Plant, Equipment : €-627 Mil (TTM As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Shanghai Fosun Pharmaceutical (Group) Co Purchase Of Property, Plant, Equipment?

Shanghai Fosun Pharmaceutical (Group) Co's purchase of property, plant, equipment for the three months ended in Mar. 2024 was €-160 Mil. It means Shanghai Fosun Pharmaceutical (Group) Co spent €160 Mil on purchasing property, plant, equipment. Shanghai Fosun Pharmaceutical (Group) Co's purchase of property, plant, equipment for the trailing twelve months (TTM) ended in Mar. 2024 was €-627Mil.

Compared with last quarter (€-144 Mil in Dec. 2023 ), Shanghai Fosun Pharmaceutical (Group) Co spent more money on purchasing property, plant, equipment in Mar. 2024 (€-160 Mil).


Shanghai Fosun Pharmaceutical (Group) Co Purchase Of Property, Plant, Equipment Historical Data

The historical data trend for Shanghai Fosun Pharmaceutical (Group) Co's Purchase Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Fosun Pharmaceutical (Group) Co Purchase Of Property, Plant, Equipment Chart

Shanghai Fosun Pharmaceutical (Group) Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Purchase Of Property, Plant, Equipment
Get a 7-Day Free Trial Premium Member Only Premium Member Only -508.41 -557.75 -690.96 -797.38 -685.38

Shanghai Fosun Pharmaceutical (Group) Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Purchase Of Property, Plant, Equipment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -230.84 -159.75 -163.69 -143.74 -160.26

Shanghai Fosun Pharmaceutical (Group) Co Purchase Of Property, Plant, Equipment Calculation

The amount used to purchase PPE.

Purchase Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-627 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Fosun Pharmaceutical (Group) Co Purchase Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Shanghai Fosun Pharmaceutical (Group) Co's Purchase Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Fosun Pharmaceutical (Group) Co (STU:08HH) Business Description

Traded in Other Exchanges
Address
No. 1289 Yishan Road, Building A, Fosun Technology Park, Shanghai, CHN, 200233
Shanghai Fosun Pharmaceutical (Group) Co Ltd is a specialty and generic drug manufacturing company. Shanghai Fosun maintains five business segments, including Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. Most of the company's revenue is generated by its Pharmaceutical manufacturing segment. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Shanghai Fosun Pharmaceutical (Group) Co (STU:08HH) Headlines

No Headlines